Details

Autor(en) / Beteiligte

• Wang, Jing‐Bo
• Huang, Xue
• Li, Fu‐Rong

Titel

Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives

Ist Teil von

• Cancer communications (London, England), 2019-07, Vol.39 (1), p.1-11

Ort / Verlag

London: BioMed Central

Erscheinungsjahr

2019

Link zum Volltext

Quelle

Wiley-Blackwell Full Collection

Beschreibungen/Notizen

• Lung cancer is the leading cause of cancer mortality worldwide. Dendritic cells (DCs) are the key factors providing protective immunity against lung tumors and clinical trials have proven that DC function is reduced in lung cancer patients. It is evident that the immunoregulatory network may play a key role in the failure of the immune response to terminate tumors. Lung tumors likely employ numerous strategies to suppress DC‐based anti‐tumor immunity. Here, we summarize the recent advances in our understanding on lung tumor‐induced immunosuppression in DCs, which affects the initiation and development of T‐cell responses. We also describe which existing measures to restore DC function may be useful for clinical treatment of lung tumors. Furthering our knowledge of how lung cancer cells alter DC function to generate a tumor‐supportive environment will be essential in order to guide the design of new immunotherapy strategies for clinical use.